Jefferies keeps EUR 15 target for Azelis stock ahead of results

Published on 10/21/2026 at 09:57 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Azelis posted first-half revenue of EUR 2.2 billion, up 3.20 percent. Azelis stock costs EUR 12.94 on October 21, 2026 against a EUR 15.00 target.

Results and valuation milestones

Jefferies reiterated a EUR 15.00 target for Azelis on October 12, 2026.
First-half 2026 revenue reached EUR 2.2 billion, up 3.20 percent year over year.
Azelis stock traded at EUR 12.94 at 9:47 a.m. CEST at Lang & Schwarz on October 21, 2026.
First-half results are due on October 22, 2026.

Azelis, BE0974400328, Illustration mit AI erstellt.

Azelis stock (ISIN BE0974400328) traded at EUR 12.94 at Lang & Schwarz on October 21, 2026 at 9:47 a.m. CEST. The immediate catalyst is a Jefferies view dated October 12, 2026, which retained a EUR 15.00 price target ahead of the company's first-half results.

According to The Asset, analyst David Kerstens expects Azelis third-quarter EBITA to recover 10.00 percent to EUR 108.00 million. The estimate is 5.00 percent below a EUR 113.40 million consensus, while the full-year 2026 EBITA forecast is EUR 424.40 million against consensus of EUR 436.00 million.

What will the results show?

Azelis generated first-half 2026 revenue of EUR 2.20 billion, an increase of 3.20 percent year over year in constant currency. Adjusted EBITDA reached EUR 233.00 million, up 2.60 percent, while the adjusted EBITDA margin was 10.70 percent. These figures come from the company's first-half earnings presentation carried by Yahoo Finance.

The regional split gives investors a clear measuring point. First-half revenue in Asia Pacific rose 8.20 percent to EUR 428.00 million, while EMEA revenue increased 1.70 percent to EUR 990.00 million. The company said its objective was positive full-year EBITDA growth, with working capital and regional demand remaining important variables.

Three ownership milestones

On September 15, 2026, Business Wire reported UBS holdings and instruments totaling 3.04 percent of Azelis voting rights. On October 8, 2026, UBS reported a 3.01 percent position in another disclosure, and on October 13, 2026, it reported a combined 3.02 percent position in the latest notice.

Which dates matter next?

Azelis is scheduled to publish its third-quarter results on October 22, 2026, according to The Asset. The fiscal-year 2026 results are scheduled for February 18, 2027, according to Simply Wall St.

Valuation meets operating recovery

Jefferies' EUR 15.00 target sits above the Lang & Schwarz indication, but the upcoming report will test whether the expected EBITA recovery is visible in volumes and margins. Azelis combines specialty chemicals and food ingredients distribution across Life Sciences and Industrial Chemicals, and is listed on Euronext Brussels under ticker AZE.

Azelis was trading at EUR 12.94 at Lang & Schwarz on October 21, 2026 at 9:47 a.m. CEST.

The further course of trading is shown by the continuously updated real-time quote of Azelis stock.